Durham drug firm Chimerix rejects call from stockholder for liquidation Source Cluster: WRAL Techwire Source Node: 1754733Time Stamp: Nov 11, 2022
Durham biopharma company Chimerix completes $238M+ deal Source Cluster: WRAL Techwire Source Node: 1697938Time Stamp: Sep 27, 2022